🔬
Foundation Sciences · Genetics
Epigenetics
Epigenetics describes heritable changes in gene expression without changes in DNA sequence, mediated by DNA methylation, histone modification and non-coding RNAs.
📌 Learning Objectives
- Describe the underlying mechanism of Epigenetics.
- Identify the key clinical features and complications of Epigenetics.
- Outline the appropriate investigations and management of Epigenetics.
- Discuss the implications for patients and families of Epigenetics.
📋 Overview
Epigenetic dysregulation contributes to cancer, ageing, and complex diseases. Targeted epigenetic therapies (e.g. azacitidine, decitabine) are used in haematological malignancies.
🔬 Basic Science
Epigenetic dysregulation contributes to cancer, ageing, and complex diseases. Targeted epigenetic therapies (e.g. azacitidine, decitabine) are used in haematological malignancies.
🏥 Clinical Relevance
Imprinting disorders are classic examples of epigenetic disease.
🧪 Investigations
Investigation depends on clinical context: relevant blood tests, imaging, and specific genetic or histopathological tests as appropriate. Refer to specialist services where indicated.
💊 Management
Management is condition-specific and typically multidisciplinary, combining medical therapy, surgical intervention where appropriate, supportive care, and family/genetic counselling.
Revision Resources – expand the sections below for high-yield notes, exam pearls, key facts and further reading.
MLA High-Yield Notes & Quick Revision ⌄
Common SBA themes: recognising the underlying mechanism, identifying classic clinical features, and choosing the first-line investigation or management step. Watch for inheritance pattern and characteristic associations.
epigenetics
methylation
histone
azacitidine
cpg island
- DNA methylation typically silences gene expression at CpG islands.
- Histone acetylation generally increases transcription; deacetylation reduces it.
- Hypermethylation of tumour suppressor promoters silences them in cancer.
- Azacitidine and decitabine are hypomethylating agents used in MDS/AML.
- Epigenetic changes can be heritable across cell divisions.
Exam Pearls ⌄
⭐ High Yield
DNA methylation typically silences gene expression at CpG islands.
Histone acetylation generally increases transcription; deacetylation reduces it.
Hypermethylation of tumour suppressor promoters silences them in cancer.
Azacitidine and decitabine are hypomethylating agents used in MDS/AML.
Epigenetic changes can be heritable across cell divisions.
💡 Clinical Pearl
Epigenetics: Imprinting disorders are classic examples of epigenetic disease.
⚠️ Exam Tip — Common Mistakes
Confusing the mechanism of Epigenetics with related conditions.
Missing classic clinical features of Epigenetics in SBA stems.
Failing to consider Epigenetics in the differential diagnosis.
Key Facts ⌄
DNA methylation typically silences gene expression at CpG islands.
Histone acetylation generally increases transcription; deacetylation reduces it.
Hypermethylation of tumour suppressor promoters silences them in cancer.
Azacitidine and decitabine are hypomethylating agents used in MDS/AML.
Epigenetic changes can be heritable across cell divisions.
Related Topics ⌄
References ⌄
- GMC MLA Content Map
- NICE Clinical Knowledge Summaries
- BMJ Best Practice
Further Resources
Medical Portfolio & Career Development
Build a professional portfolio website for applications, audits, teaching, research and career progression.
CVtoWebsite.com →